Manulife (Manufacturers Life Insurance)
PASG icon

Manulife (Manufacturers Life Insurance)’s Passage Bio PASG Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,076
Closed -$137 – 3161
2021
Q4 		$137 Buy
1,076
+32
+3% +$5.23K ﹤0.01% 3002
2021
Q3 		$208K Sell
1,044
-54
-5% -$12.9K ﹤0.01% 2957
2021
Q2 		$291K Buy
1,098
+250
+29% +$77.3K ﹤0.01% 2837
2021
Q1 		$297K Buy
848
+91
+12% +$38.9K ﹤0.01% 2631
2020
Q4 		$387K Buy
+757
New +$303K ﹤0.01% 2358
2020
Q3 		– Sell
-395
Closed -$219K – 2929
2020
Q2 		$219K Buy
+395
New +$178K ﹤0.01% 2452

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PASG Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Passage Bio (PASG) in Q1 2022, closing a stake of 1,076 shares — an estimated $137 sold.

Manulife (Manufacturers Life Insurance) first reported a position in PASG in Q2 2020 and held it in 6 quarters. The position peaked at $387K in Q4 2020. 108 funds tracked by Wall St. Rank hold PASG as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Passage Bio position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,076 Passage Bio shares in Q1 2022, an estimated $137.
  • Manulife (Manufacturers Life Insurance) first reported a position in Passage Bio in Q2 2020 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s Passage Bio position peaked at $387K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Passage Bio as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.